middle.news
How Will Rhythm Biosciences Use $1M to Transform Cancer Diagnostics?
7:03pm on Monday 30th of June, 2025 AEST
•
Healthcare
Read Story
How Will Rhythm Biosciences Use $1M to Transform Cancer Diagnostics?
7:03pm on Monday 30th of June, 2025 AEST
Key Points
Secured $1 million non-dilutive loan from Endpoints Capital
Loan repayable via FY2025 Research and Development Tax Incentive rebate
Funding supports ColoSTAT® multiplex assay commercial launch
Expansion of geneType™ genetic risk assessment platform
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RHYTHM BIOSCIENCES (ASX:RHY)
OPEN ARTICLE